The Effectiveness of Plecanatide for Treating Constipation and Bloating in Patients Aged 18 to 40 Years With Irritable Bowel Syndrome: Utilization of a New Composite Trisymptom Endpoint

By afschroeder • November 11, 2025

Brenner DM, Shin AS, Laitman AP, Deutsch JK, Kunkel DC. The Effectiveness of Plecanatide for Treating Constipation and Bloating in Patients Aged 18 to 40 Years With Irritable Bowel Syndrome: Utilization of a New Composite Trisymptom Endpoint. J Gastroenterol Hepatol. 2025 Nov 10. doi: 10.1111/jgh.70119. Epub ahead of print. PMID: 41214272.

Tags: abdominal pain, bloating, constipation, Digestive Diseases, guanylate cyclase C agonists, Irritable Bowel Syndrome, Publications

Related Posts

Closing the completion colonoscopy gap: key takeaways from the American Society for Gastrointestinal Endoscopy’s 2025 National Colorectal Cancer Screening Summit

Hosseini-Carroll P, Dominitz JA, Jacobson BC, May FP, Issaka RB, Schmitt CM, Adams TL, Boston IJ, Bucobo JC, Day L, Khaykis IB, Marino MJ, Rex[...]

Reflections on the Rome V Criteria for Disorders of the Gut-Brain Interaction: Where Do We Go From Here?

Keszthelyi D, Butt MF, Malcolm A, Reed D, Santucci N, Shin A, Visaggi P. Reflections on the Rome V Criteria for Disorders of the Gut-Brain[...]

Altered bile acid metabolism in people with HIV correlates with systemic and intestinal inflammation

Irwin S, Elliott J, Li F, Ruiz P, Anton PA, Du X, Fulcher JA. Altered bile acid metabolism in people with HIV correlates with systemic[...]